Calpain 1 in bronchoalveolar lavage fluid is associated with poor prognosis in lepidic predominant pulmonary adenocarcinoma.


Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 26 09 2018
accepted: 14 11 2018
pubmed: 27 1 2019
medline: 8 3 2019
entrez: 27 1 2019
Statut: ppublish

Résumé

Calpain 1 is a proinflammatory calcium-activated cysteine protease, which can be partly externalized. Extracellular calpains limit inflammatory processes and promote tissue repair, through cell proliferation and migration. Toll like receptor (TLR) 2 has been identified as a target of extracellular calpains in lymphocytes. The aim was to investigate the externalization of calpain 1 and the release of soluble TLR2 during tumor progression of pulmonary lepidic predominant adenocarcinoma (LPA). Extracellular calpain 1, soluble fragment of TLR2 and cytokines were analyzed by ELISA in bronchoalveolar lavage fluid (BALF) supernatants from patients with LPA (n=68). Source of calpain was analyzed by immunohistochemistry and soluble TLR2 by flow cytometry on polymorphonuclear neutrophils (PMN) and human lung cancer cell lines. Extracellular calpain 1, secreted by tumor cells, was associated to tumor progression, neutrophilic inflammation, with a poor prognostic factor on survival (P=0.003). TLR2 was expressed on PMN and tumor cells and decreased after calpain exposure. Soluble fragment of TLR2 in BALF supernatants was correlated to the extracellular calpain 1 concentration (r=0.624; P<0.001), and its high level was associated with tumor progression and a pro-inflammatory environment. Extracellular calpain 1 secreted by tumor cells, could participate in inflammatory microenvironment and tumor progression through TLR2 in LPA.

Identifiants

pubmed: 30683309
pii: S0007-4551(18)30374-6
doi: 10.1016/j.bulcan.2018.11.014
pii:
doi:

Substances chimiques

Neoplasm Proteins 0
TLR2 protein, human 0
Toll-Like Receptor 2 0
Calpain EC 3.4.22.-
CAPN1 protein, human EC 3.4.22.52

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-188

Informations de copyright

Copyright © 2018 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Anne-Marie Ruppert (AM)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France; Hôpitaux universitaires de l'est parisien, hôpital Tenon (AP-HP), service de pneumologie, 75970 Paris, France.

Laurent Baud (L)

Sorbonne Universités, UMR_S1155 and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), 4, rue de la Chine, 75252 Paris, France; Inserm, UMR_S1155, 75020 Paris, France.

Nathalie Rabbe (N)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France; Hôpitaux universitaires de l'est parisien, hôpital Tenon (AP-HP), service de pneumologie, 75970 Paris, France; Paris Descartes université, équipe « cancer, immune control and escape », centre de recherche des Cordeliers, Inserm UMR_S1138, 75006 Paris, France; AP-HP, hôpitaux universitaires Paris centre, hôpital Cochin, unité d'oncologie thoracique, service de pneumologie, 75014 Paris, France.

Joëlle Perez (J)

Sorbonne Universités, UMR_S1155 and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), 4, rue de la Chine, 75252 Paris, France.

Michaël Duruisseaux (M)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France.

Thibault Vieira (T)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France.

Martine Antoine (M)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France; AP-HP, hôpitaux universitaires de l'est parisien, hôpital Tenon, service de cytologie et anatomie pathologique, 75970 Paris, France.

Jacques Cadranel (J)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France; Hôpitaux universitaires de l'est parisien, hôpital Tenon (AP-HP), service de pneumologie, 75970 Paris, France.

Marie Wislez (M)

Sorbonne université, GRC n(o) 04, Theranoscan, 75252 Paris, France; Hôpitaux universitaires de l'est parisien, hôpital Tenon (AP-HP), service de pneumologie, 75970 Paris, France; Paris Descartes université, équipe « cancer, immune control and escape », centre de recherche des Cordeliers, Inserm UMR_S1138, 75006 Paris, France; AP-HP, hôpitaux universitaires Paris centre, hôpital Cochin, unité d'oncologie thoracique, service de pneumologie, 75014 Paris, France. Electronic address: marie.wislez@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH